Overview

Folinic Acid in Autism

Status:
Completed

Trial end date:
2018-06-30

Target enrollment:

Participant gender:

Summary

An examination of changes in urinary metabolites with use of folinic acid in children with autism spectrum disorder (ASD). Investigators will also measure behavioral measures and academic measures monthly at school with teachers and parents report.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

University of California, San Francisco

Treatments:

Folic Acid
Leucovorin
Levoleucovorin